IDERA
"IDERA" is a word and design mark owned by Idera Pharmaceuticals, Inc., filed at the USPTO on September 25, 2019. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since December 15, 2020
- Filed
- September 25, 2019
- Registered
- December 15, 2020
- Expires
- Not recorded
- Application no.
- 88631158
- Registration no.
- 6223085
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 1 class
Who owns IDERA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Idera Pharmaceuticals, Inc.
Cambridge, United States
Representative
Rebecca E. McDougall
Morgan, Lewis & Bockius LLP
What the mark covers
The products and services IDERA is filed for, grouped by Nice class.
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
What has happened so far
Steps recorded by the USPTO, newest first.
- Courtesy reminder - sec. 8 (6-yr) e-mailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Statement of use processing complete
- Case assigned to intent to use paralegal
- Use amendment filed
- Teas statement of use received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
7 earlier steps on the official record.
About IDERA
Who owns the trademark "IDERA"?
The USPTO trademark "IDERA" (application 88631158) is owned by Idera Pharmaceuticals, Inc.
What is the status of "IDERA"?
Its status at the USPTO is: registered.
When was "IDERA" registered?
It was registered on December 15, 2020.
Get this data via the API
Everything on this page comes from the Signa API. Pull IDERA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b02-8fba-7066-a86d-7308da140975
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b02-8fba-7066-a86d-7308da140975",
"object": "trademark",
"mark_text": "IDERA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "88631158",
"filing_date": "2019-09-25",
"nice_classes": [
5
],
"owners": [
{
"name": "Idera Pharmaceuticals, Inc.",
"entity_id": "ent_019eb6fd-1659-74bb-a53a-858fe0edaf6e"
}
]
}